DK1152763T3 - Anvendelse af desozypeganin til behandling af stofafhængighed - Google Patents

Anvendelse af desozypeganin til behandling af stofafhængighed

Info

Publication number
DK1152763T3
DK1152763T3 DK00910649T DK00910649T DK1152763T3 DK 1152763 T3 DK1152763 T3 DK 1152763T3 DK 00910649 T DK00910649 T DK 00910649T DK 00910649 T DK00910649 T DK 00910649T DK 1152763 T3 DK1152763 T3 DK 1152763T3
Authority
DK
Denmark
Prior art keywords
treatment
drug dependence
desozypeganine
drug
desoxypeganine
Prior art date
Application number
DK00910649T
Other languages
Danish (da)
English (en)
Inventor
Bodo Asmussen
Thomas Hille
Hans-Rainer Hoffmann
Klaus Opitz
Original Assignee
Hf Arzneimittelforsch Gmbh
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh, Lohmann Therapie Syst Lts filed Critical Hf Arzneimittelforsch Gmbh
Application granted granted Critical
Publication of DK1152763T3 publication Critical patent/DK1152763T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00910649T 1999-02-19 2000-02-08 Anvendelse af desozypeganin til behandling af stofafhængighed DK1152763T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19906978A DE19906978B4 (de) 1999-02-19 1999-02-19 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
PCT/EP2000/000974 WO2000048582A2 (de) 1999-02-19 2000-02-08 Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der drogenabhängigkeit

Publications (1)

Publication Number Publication Date
DK1152763T3 true DK1152763T3 (da) 2003-03-24

Family

ID=7898024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00910649T DK1152763T3 (da) 1999-02-19 2000-02-08 Anvendelse af desozypeganin til behandling af stofafhængighed

Country Status (10)

Country Link
US (1) US6599511B1 (ko)
EP (1) EP1152763B1 (ko)
JP (1) JP2002537246A (ko)
KR (1) KR20010102239A (ko)
AT (1) ATE228843T1 (ko)
AU (1) AU3278800A (ko)
DE (2) DE19906978B4 (ko)
DK (1) DK1152763T3 (ko)
ES (1) ES2188513T3 (ko)
WO (1) WO2000048582A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
DE10304141B4 (de) 2003-02-03 2006-03-09 Hf Arzneimittelforschung Gmbh Verfahren zur Herstellung von Chinazolin-Alkaloiden
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
RU2460515C1 (ru) * 2011-10-17 2012-09-10 Тагир Рафаилович Гизатуллин Способ дезинтоксикационно-инфузионного лечения больных при употреблении дезоморфина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
DE4301782C1 (de) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
US5591738A (en) * 1994-10-14 1997-01-07 Nda International, Inc. Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung

Also Published As

Publication number Publication date
DE19906978B4 (de) 2004-07-08
ES2188513T3 (es) 2003-07-01
DE50000864D1 (de) 2003-01-16
JP2002537246A (ja) 2002-11-05
AU3278800A (en) 2000-09-04
ATE228843T1 (de) 2002-12-15
WO2000048582A3 (de) 2001-04-12
KR20010102239A (ko) 2001-11-15
EP1152763B1 (de) 2002-12-04
DE19906978A1 (de) 2000-08-24
US6599511B1 (en) 2003-07-29
EP1152763A2 (de) 2001-11-14
WO2000048582A2 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
ATE339954T1 (de) Kombinationen von formoterol und tiotropium-salz
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
BR0011894A (pt) Forma de dosagem oral, processo para a fabricação de forma de dosagem, uso de forma de dosagem farmacêutica oral, e, métodos para aumentar inibição de secreção do ácido gástrico e para aumentar o efeito terapêutico no tratamento de distúrbios gastrointestinais associados com excesso de secreção ácida
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
ATE292453T1 (de) Antivirale arznei
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ATA59499A (de) Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
WO2000048445A3 (de) Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
DK1152763T3 (da) Anvendelse af desozypeganin til behandling af stofafhængighed
DK1154776T3 (da) Farmaceutisk sammensætning, indeholdende desoxypeganin til behandling af alkoholisme
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
GB9917290D0 (en) Pharmaceutical composition
DE69918124D1 (de) Formulierungen zur transdermalen verabreichung von fenoldopam
HUP0301026A2 (hu) Arginin alkalmazása gyógyszer előállításában a gyógyszerek intravénás beadásával társuló mellékhatások megelőzésére és kezelésére
SE9802555D0 (sv) New pharmaceutical preparation and method